✦ LIBER ✦
0185 High-dose fulvestrant (500 mg): Clinical evidence supporting potentially improved efficacy benefits in hormone receptor-positive (HR+) advanced breast cancer (ABC)
✍ Scribed by N. Harbeck; I. Kuter; D. Amakye; J.F.R. Robertson; M.J. Ellis
- Book ID
- 114316314
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 52 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0960-9776
No coin nor oath required. For personal study only.